Oxurion NV (Germany) Performance
| TG4 Stock | EUR 0.28 0.00 0.00% |
The company holds a Beta of 1.95, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Oxurion NV will likely underperform. Oxurion NV right now holds a risk of 0.0%. Please check Oxurion NV mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance , to decide if Oxurion NV will be following its historical price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Oxurion NV has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Oxurion NV is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 24.5 M | |
| Total Cashflows From Investing Activities | 407 K | |
| Free Cash Flow | -27 M |
Oxurion |
Oxurion NV Relative Risk vs. Return Landscape
If you would invest (100.00) in Oxurion NV on August 27, 2024 and sell it today you would earn a total of 100.00 from holding Oxurion NV or generate -100.0% return on investment over 90 days. Oxurion NV is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded stocks are less volatile than Oxurion, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Oxurion NV Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oxurion NV's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Oxurion NV, and traders can use it to determine the average amount a Oxurion NV's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| TG4 |
Based on monthly moving average Oxurion NV is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oxurion NV by adding Oxurion NV to a well-diversified portfolio.
Oxurion NV Fundamentals Growth
Oxurion Stock prices reflect investors' perceptions of the future prospects and financial health of Oxurion NV, and Oxurion NV fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Oxurion Stock performance.
| Return On Equity | -6.94 | |||
| Return On Asset | -1.01 | |||
| Operating Margin | (24.31) % | |||
| Current Valuation | 9.4 M | |||
| Shares Outstanding | 584.7 M | |||
| Price To Earning | 6.84 X | |||
| Price To Book | 5.41 X | |||
| Price To Sales | 2.81 X | |||
| Revenue | 1.13 M | |||
| EBITDA | (27.76 M) | |||
| Cash And Equivalents | 85.13 M | |||
| Cash Per Share | 2.22 X | |||
| Total Debt | 8.43 M | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (26.98 M) | |||
| Earnings Per Share | (0.71) X | |||
| Total Asset | 18.88 M | |||
About Oxurion NV Performance
By analyzing Oxurion NV's fundamental ratios, stakeholders can gain valuable insights into Oxurion NV's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Oxurion NV has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Oxurion NV has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Oxurion NV, an integrated biopharmaceutical company, develops and commercializes medicines that address unmet clinical needs in ophthalmology in Belgium and internationally. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium. ThromboGenics operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 78 people.Things to note about Oxurion NV performance evaluation
Checking the ongoing alerts about Oxurion NV for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Oxurion NV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Oxurion NV is not yet fully synchronised with the market data | |
| Oxurion NV has some characteristics of a very speculative penny stock | |
| Oxurion NV has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 1.13 M. Net Loss for the year was (29.16 M) with profit before overhead, payroll, taxes, and interest of 516 K. | |
| Oxurion NV has accumulated about 85.13 M in cash with (26.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.22, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Oxurion NV's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Oxurion NV's stock is overvalued or undervalued compared to its peers.
- Examining Oxurion NV's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Oxurion NV's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Oxurion NV's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Oxurion NV's stock. These opinions can provide insight into Oxurion NV's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Oxurion Stock analysis
When running Oxurion NV's price analysis, check to measure Oxurion NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oxurion NV is operating at the current time. Most of Oxurion NV's value examination focuses on studying past and present price action to predict the probability of Oxurion NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oxurion NV's price. Additionally, you may evaluate how the addition of Oxurion NV to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |